Cargando…
Ursodeoxycholic Acid in Patients With Treatment-Resistant Schizophrenia Suffering From Coronavirus Disease 2019: A Hypothesis Letter
Autor principal: | Khosravi, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079749/ https://www.ncbi.nlm.nih.gov/pubmed/33935842 http://dx.doi.org/10.3389/fpsyt.2021.657316 |
Ejemplares similares
-
Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
por: Khosravi, Mohsen
Publicado: (2020) -
Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
por: Khosravi, Mohsen
Publicado: (2021) -
Ethical Implications of the Mild Encephalitis Hypothesis of Schizophrenia
por: Riedmüller, Rita, et al.
Publicado: (2017) -
Mental Symptoms and Stress of Hospitalized Schizophrenia Patients With 2019 Novel Coronavirus Disease: An Observation Study
por: Ma, Jun, et al.
Publicado: (2021) -
How Will the Mild Encephalitis Hypothesis of Schizophrenia Influence Stigmatization?
por: Müller, Sabine, et al.
Publicado: (2017)